Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts
复制标题
使用两个英国队列的初级保健记录分析难治性抑郁症的遗传和临床特征
DOI:
10.1101/2020.08.24.20178715
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Fabbri C
中科院分区:
文献类型:
--
作者:
Fabbri C
Treatment-resistant depression (TRD) is a major contributor to the disability caused by major depressive disorder (MDD). Primary care electronic health records provide an easily accessible approach to investigate TRD clinical and genetic characteristics. MDD defined from primary care records in UK Biobank (UKB) and EXCEED studies was compared with other measures of depression and tested for association with MDD polygenic risk score (PRS). Using prescribing records, TRD was defined from at least two switches between antidepressant drugs, each prescribed for at least 6 weeks. Clinical-demographic characteristics, SNP-based heritability (h2SNP) and genetic overlap with psychiatric and non-psychiatric traits were compared in TRD and non-TRD MDD cases. In 230,096 and 8926 UKB and EXCEED participants with primary care data, respectively, the prevalence of MDD was 8.7% and 14.2%, of which 13.2% and 13.5% was TRD, respectively. In both cohorts, MDD defined from primary care records was strongly associated with MDD PRS, and in UKB it showed overlap of 71–88% with other MDD definitions. In UKB, TRD vs healthy controls and non-TRD vs healthy controlsh2SNPwas comparable (0.25 [SE = 0.04] and 0.19 [SE = 0.02], respectively). TRD vs non-TRD was positively associated with the PRS of attention deficit hyperactivity disorder, with lower socio-economic status, obesity, higher neuroticism and other unfavourable clinical characteristics. This study demonstrated that MDD and TRD can be reliably defined using primary care records and provides the first large scale population assessment of the genetic, clinical and demographic characteristics of TRD.
登录
查看更多内容
DOI:
10.3390/ijerph15122763
发表时间:
2018-12-01
影响因子:
--
作者:
Wlodarczyk, Julian;Lawn, Sharon;Litt, John
通讯作者:
Litt, John
影响因子:
7.4
作者:
Cepeda MS;Reps J;Ryan P
通讯作者:
Ryan P
DOI:
--
发表时间:
2017-07
期刊:
--
影响因子:
--
作者:
T. Vos;A. Abajobir;C. Abbafati;K. Abbas;K. H. Abate;F. Abd-Allah;A. Abdulle;Teshome Abuka Abebo-
通讯作者:
T. Vos;A. Abajobir;C. Abbafati;K. Abbas;K. H. Abate;F. Abd-Allah;A. Abdulle;Teshome Abuka Abebo-
影响因子:
30.8
作者:
Pardiñas AF;Holmans P;Pocklington AJ;Escott-Price V;Ripke S;Carrera N;Legge SE;Bishop S;Cameron D;Hamshere ML;Han J;Hubbard L;Lynham A;Mantripragada K;Rees E;MacCabe JH;McCarroll SA;Baune BT;Breen G;Byrne EM;Dannlowski U;Eley TC;Hayward C;Martin NG;McIntosh AM;Plomin R;Porteous DJ;Wray NR;Caballero A;Geschwind DH;Huckins LM;Ruderfer DM;Santiago E;Sklar P;Stahl EA;Won H;Agerbo E;Als TD;Andreassen OA;Bækvad-Hansen M;Mortensen PB;Pedersen CB;Børglum AD;Bybjerg-Grauholm J;Djurovic S;Durmishi N;Pedersen MG;Golimbet V;Grove J;Hougaard DM;Mattheisen M;Molden E;Mors O;Nordentoft M;Pejovic-Milovancevic M;Sigurdsson E;Silagadze T;Hansen CS;Stefansson K;Stefansson H;Steinberg S;Tosato S;Werge T;GERAD1 Consortium;CRESTAR Consortium;Collier DA;Rujescu D;Kirov G;Owen MJ;O'Donovan MC;Walters JTR
通讯作者:
Walters JTR
DOI:
--
发表时间:
2019
期刊:
影响因子:
--
作者:
C. John;N. Reeve;R. Free;A. T. Williams;Aliki;J. Bethea;L. Barton;N. Shrine;C. Batini;R. Packer;S. Terry;B. Hargadon;Qingning Wang;C. Melbourne;E. Adams;C. Bee;K. Harrington;J. Miola;N. Brunskill;C. Brightling;J. Barwell;S. Wallace;Ron T Hsu;D. Shepherd;E. Hollox;L. Wain;M. Tobin
通讯作者:
M. Tobin